Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many immunocompromised patients of (a) working age and (b) all ages did not receive their ordered antiviral courses within five days of first experiencing symptoms from covid-19, as recommended by the Medicines and Healthcare products Regulatory Agency.

To date, 21,405 individuals in England have been prescribed an antiviral-based COVID-19 treatment under the clinical access policy for non-hospitalised patients at highest risk from infection due to a compromised immune response. Of these, 1,079 people of all ages and 800 aged 17 to 69 years old received an antiviral treatment more than five days from the date of recorded symptom onset. Under the policy, patients can be treated with the antiviral remdesivir within seven days of symptom onset.